COVID-19: Vaccines and Therapeutics
The Food and Drug Administration Center for Biologics Evaluation and Research Prevention has addressed new information that shipped vials of Pfizer’s BND162b2 mRNA COVID-19 vaccine contain extra doses, indicating that it is acceptable to use every full dose obtainable from each product vial.
Please join AHA Board Chair Melinda Estes, M.D., for the eleventh in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes was joined by Rodney F. Hochman, M.D., President and CEO,…
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- COVID-19: Organizational Preparedness and Capacity Planning
- COVID-19: Protecting Health Care Workers
- Workforce
- Workforce Shortages
- Well-Being & Resilience
- COVID-19: Caring for Patients and Communities
- COVID-19: Supplies and Personal Protective Equipment (PPE)
- COVID-19: Vaccines and Therapeutics
- Leadership Dialogue
In this conversation, Nancy Foster, Vice President for Quality and Patient Safety Policy, talks with Sonia Perez, Chief Operating Officer, UnidosUS, and Clint Odom, Senior Vice President, Policy & Advocacy, National Urban League and Executive Director, National Urban League’s Washington Bureau…
As a physician, nurse, respiratory therapist, environmental services or food services worker or other health care professional, your example is one of the strongest health resources we have. When you get your COVID-19 vaccine, please consider sharing your story to help others understand the…
Special Bulletin
The Food and Drug Administration (FDA) last week granted an emergency use authorization (EUA) to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine. As you are aware, distribution and administration of the first shipments are well underway across the country.
The Centers for Disease Control and Prevention will award states and territories another $227 million in funding from the Coronavirus Aid, Relief, and Economic Security Act and Paycheck Protection Program and Health Care Enhancement Act for COVID-19 vaccine preparedness and complementary activities…
In an open letter, the AHA, American Medical Association and American Nurses Association thanked health care professionals for their dedication and sacrifices this year and urged them to continue their battle against COVID-19 by taking a vaccine and sharing their experience with others.
Ahead of a Dec. 17 meeting of its Vaccines and Related Biological Products Advisory Committee, the Food and Drug Administration released a briefing document confirming Moderna’s data on the safety and efficacy of the mRNA-1273 COVID-19 vaccine candidate.
December 15, 2020
An open letter to all health care professionals:
The Centers for Medicare & Medicaid Services recently posted information on how hospitals and other health care providers should bill Medicare for administering COVID-19 vaccines.